To testify that our hypothesis that ultrasound-targeted MB destruction (UTMD) could modulate the suppressed immune response and promote PDL-1 blockade therapy to inhibit tumor progression by striking tumor-induced CEC in the spleen, the Lewis lung cancer (LLC) animal model was built. Here, CD274 is linked to neoplasm.